Live
- Tragic Road Accident in Anantapur District Claims Four Lives
- I bow down to voters' decision: Kumaraswamy’s son on bypolls defeat
- Priyanka's resemblance with Indira Gandhi only in appearance: Robert Vadra
- NDA predicts victory in 2025 Assembly elections after winning Bihar bypolls
- Rahul Gandhi failed once again: Pralhad Joshi on poll results
- Jarange-Patil's pro-Maratha reservation cry fails to hamper MahaYuti’s performance
- After MVA's demolition, the 15th Maharashtra Assembly may not have LoP
- Pentagon official says burden sharing with South Korea is not just about defence spending
- Pakistan braces for more sectarian bloodshed after killing of 43 Shias
- BJP in Tripura doubles its membership: Party leader
US FDA authorizes Pfizer-BioNTech boosters for kids aged 12-15
US FDA authorizes Pfizer-BioNTech boosters for kids aged 12-15
The US Food and Drug Administration (FDA) has expanded the emergency use authorization for the Pfizer-BioNTech Covid-19 vaccine boosters to children aged 12 to 15.
Washington: The US Food and Drug Administration (FDA) has expanded the emergency use authorization for the Pfizer-BioNTech Covid-19 vaccine boosters to children aged 12 to 15.
On Monday, the FDA also shortened the time for booster shots from at least six months after completion of the initial series to at least five months, for everyone aged 12 and older, reports Xinhua news agency.
The agency has determined that the protective health benefits of a single booster dose of the Pfizer-BioNTech Covid-19 vaccine to provide continued protection against the virus and the associated serious consequences outweigh the potential risks in individuals aged 12 to 15.
The agency said that it found "no new safety concerns" following a booster shot in young teenagers, and that there were no new reports of two types of heart inflammation called myocarditis or pericarditis linked to the boosters.
The decision came as the Omicron variant is spreading rapidly across the US and has led to record high hospitalisations among younger people.
